Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results From the VOLVER Clinical Trial.

De Lagarde M, De Miguel R, Sigcha MA, Blanco JL, Pinto-Martinez A, Montejano R, Gutiérrez Liarte A, Navarro-Soler R, Cañas-Ruano E, Inciarte A, Martin-Carbonero L, Imaz A, Hernández Gutiérrez C, Ocampo A, de Miguel M, Delgado R, Pulido F, Arribas JR, VOLVER GESIDA 11820 Study Group

Open source

DOI: 10.1093/cid/ciag060
Published: 2026 Jul 23
Container: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciag060,
  title = {Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results From the VOLVER Clinical Trial.},
  author = {De Lagarde M and De Miguel R and Sigcha MA and Blanco JL and Pinto-Martinez A and Montejano R and Gutiérrez Liarte A and Navarro-Soler R and Cañas-Ruano E and Inciarte A and Martin-Carbonero L and Imaz A and Hernández Gutiérrez C and Ocampo A and de Miguel M and Delgado R and Pulido F and Arribas JR and VOLVER GESIDA 11820 Study Group},
  year = {2026},
  journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  doi = {10.1093/cid/ciag060},
  url = {https://doi.org/10.1093/cid/ciag060}
}

RIS

TY  - JOUR
TI  - Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results From the VOLVER Clinical Trial.
AU  - De Lagarde M
AU  - De Miguel R
AU  - Sigcha MA
AU  - Blanco JL
AU  - Pinto-Martinez A
AU  - Montejano R
AU  - Gutiérrez Liarte A
AU  - Navarro-Soler R
AU  - Cañas-Ruano E
AU  - Inciarte A
AU  - Martin-Carbonero L
AU  - Imaz A
AU  - Hernández Gutiérrez C
AU  - Ocampo A
AU  - de Miguel M
AU  - Delgado R
AU  - Pulido F
AU  - Arribas JR
AU  - VOLVER GESIDA 11820 Study Group
PY  - 2026
JO  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
DO  - 10.1093/cid/ciag060
UR  - https://doi.org/10.1093/cid/ciag060
ER  -

APA

M, D. L., R, D. M., MA, S., JL, B., A, P., R, M., A, G. L., R, N., E, C., A, I., L, M., A, I., C, H. G., A, O., M, D. M., R, D., F, P., JR, A., & Group, V. G. 1. S. (2026). Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results From the VOLVER Clinical Trial.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciag060

Source records

pubmed · retrieved 2026-09-26T10:57:36.450Z